Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Australia and New Zealand Melanoma Trials Group (ANZMTG)
Scientific Title
Whole brain radiotherapy following local treatment of intracranial metastases of melanoma. A randomised phase III trial (Other IDs: ANZMTG 1-07).